Overview

The Department of Health, Disability and Ageing published a ministerial decision in the Federal Register of Legislation on 22 September 2026. The decision follows a Pharmaceutical Services Federal Committee of Inquiry report and is registered as instrument C2026G00628.

Authorising legislation

The decision is authorised under the National Health Act 1953.

What the source document says

The source page for instrument C2026G00628 does not provide detail about the content of the inquiry, what the ministerial decision covers, which pharmaceutical services are affected, or what changes are required of businesses or individuals.

Key actions

This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.